How to evaluate antiarrhythmic agents in an essentially asymptomatic population.
Identifieur interne : 001973 ( PubMed/Curation ); précédent : 001972; suivant : 001974How to evaluate antiarrhythmic agents in an essentially asymptomatic population.
Auteurs : S. Connolly [Canada]Source :
- The Canadian journal of cardiology [ 0828-282X ] ; 1994.
Descripteurs français
- Wicri :
- geographic : Canada.
English descriptors
- KwdEn :
- Anti-Arrhythmia Agents (therapeutic use), Atrial Fibrillation (drug therapy), Atrial Fibrillation (etiology), Canada, Drug Evaluation, Female, Humans, Male, Myocardial Infarction (complications), Ventricular Fibrillation (drug therapy), Ventricular Fibrillation (etiology), Wolff-Parkinson-White Syndrome (drug therapy).
- MESH :
- chemical , therapeutic use : Anti-Arrhythmia Agents.
- geographic : Canada.
- complications : Myocardial Infarction.
- drug therapy : Atrial Fibrillation, Ventricular Fibrillation, Wolff-Parkinson-White Syndrome.
- etiology : Atrial Fibrillation, Ventricular Fibrillation.
- Drug Evaluation, Female, Humans, Male.
PubMed: 8162530
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001973
Links to Exploration step
pubmed:8162530Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">How to evaluate antiarrhythmic agents in an essentially asymptomatic population.</title>
<author><name sortKey="Connolly, S" sort="Connolly, S" uniqKey="Connolly S" first="S" last="Connolly">S. Connolly</name>
<affiliation wicri:level="2"><nlm:affiliation>Faculty of Health Sciences, McMaster University, Hamilton, Ontario.</nlm:affiliation>
<country>Canada</country>
<placeName><region type="province">Ontario</region>
</placeName>
<wicri:cityArea>Faculty of Health Sciences, McMaster University, Hamilton</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1994">1994</date>
<idno type="RBID">pubmed:8162530</idno>
<idno type="pmid">8162530</idno>
<idno type="wicri:Area/PubMed/Corpus">001973</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001973</idno>
<idno type="wicri:Area/PubMed/Curation">001973</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001973</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">How to evaluate antiarrhythmic agents in an essentially asymptomatic population.</title>
<author><name sortKey="Connolly, S" sort="Connolly, S" uniqKey="Connolly S" first="S" last="Connolly">S. Connolly</name>
<affiliation wicri:level="2"><nlm:affiliation>Faculty of Health Sciences, McMaster University, Hamilton, Ontario.</nlm:affiliation>
<country>Canada</country>
<placeName><region type="province">Ontario</region>
</placeName>
<wicri:cityArea>Faculty of Health Sciences, McMaster University, Hamilton</wicri:cityArea>
</affiliation>
</author>
</analytic>
<series><title level="j">The Canadian journal of cardiology</title>
<idno type="ISSN">0828-282X</idno>
<imprint><date when="1994" type="published">1994</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anti-Arrhythmia Agents (therapeutic use)</term>
<term>Atrial Fibrillation (drug therapy)</term>
<term>Atrial Fibrillation (etiology)</term>
<term>Canada</term>
<term>Drug Evaluation</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Myocardial Infarction (complications)</term>
<term>Ventricular Fibrillation (drug therapy)</term>
<term>Ventricular Fibrillation (etiology)</term>
<term>Wolff-Parkinson-White Syndrome (drug therapy)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Arrhythmia Agents</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>Canada</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Myocardial Infarction</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Atrial Fibrillation</term>
<term>Ventricular Fibrillation</term>
<term>Wolff-Parkinson-White Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Atrial Fibrillation</term>
<term>Ventricular Fibrillation</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Drug Evaluation</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Canada</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">8162530</PMID>
<DateCreated><Year>1994</Year>
<Month>05</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted><Year>1994</Year>
<Month>05</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised><Year>2008</Year>
<Month>04</Month>
<Day>09</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0828-282X</ISSN>
<JournalIssue CitedMedium="Print"><Volume>10</Volume>
<Issue>3</Issue>
<PubDate><Year>1994</Year>
<Month>Apr</Month>
</PubDate>
</JournalIssue>
<Title>The Canadian journal of cardiology</Title>
<ISOAbbreviation>Can J Cardiol</ISOAbbreviation>
</Journal>
<ArticleTitle>How to evaluate antiarrhythmic agents in an essentially asymptomatic population.</ArticleTitle>
<Pagination><MedlinePgn>330</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Connolly</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Faculty of Health Sciences, McMaster University, Hamilton, Ontario.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Can J Cardiol</MedlineTA>
<NlmUniqueID>8510280</NlmUniqueID>
<ISSNLinking>0828-282X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000889">Anti-Arrhythmia Agents</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000889" MajorTopicYN="N">Anti-Arrhythmia Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001281" MajorTopicYN="N">Atrial Fibrillation</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004341" MajorTopicYN="N">Drug Evaluation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014693" MajorTopicYN="N">Ventricular Fibrillation</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014927" MajorTopicYN="N">Wolff-Parkinson-White Syndrome</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1994</Year>
<Month>4</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>1994</Year>
<Month>4</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>1994</Year>
<Month>4</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">8162530</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001973 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001973 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Canada |area= ParkinsonCanadaV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:8162530 |texte= How to evaluate antiarrhythmic agents in an essentially asymptomatic population. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:8162530" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a ParkinsonCanadaV1
![]() | This area was generated with Dilib version V0.6.29. | ![]() |